Clinical Trial

A Multicenter, Open-label, Single-arm, Phase II Study of NHWD-870 HCl in Adults and Adolescents with Advanced NUT Cancer

Unknown Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated January 24, 2025 (before its estimated June 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a multicenter, open-label, single-arm, phase II study to evaluate the efficacy, safety, and pharmacokinetics of NHWD-870 HCl in adults and adolescents with advanced NUT cancer.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06527300
Lead Sponsor Zhejiang Wenda Pharma Technology LTD.
Conditions Advanced Solid Tumor (Phase 1)
Enrollment 48 participants
Start Date 2024-04-25
Primary Completion 2025-06-30 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-01-24